Skip to content
Find Clinical Trials
Find Clinical Trials

S90652 in Paediatric Hypertension

Servier Protocol Code: CL2-90652-002 Sponsor: Institut de Recherches Internationales Servier Clinicaltrials.gov Identifier: NCT00202592 EudraCT Number: 2005-000474-42

Find a recruiting site

How to participate in this study
If you think you are eligible for this study (see
eligibility criteria
below), you can identify the location closest to you and contact them directly. If you can’t find a location close to you, please contact Institut de Recherches Internationales Servier (I.R.I.S.)
Name: Institut de Recherches Internationales Servier, Département des études cliniques
Phone number: +33 1 55 72 60 00
The study has 1 location

Study description

The aim of the study is to assess the long-term safety and effects on blood pressure of a paediatric formulation of perindopril in hypertensive children
Official title: Safety and Effects on Blood Pressure of Daily Dose 0.025 to 0.135 Milligram Per Kilogram of S90625 a Paediatric Formulation of Perindopril, in Hypertensive Children - 24 Months
Results
Conditions
Hypertension
Interventions / Treatments
  • Perindopril
Other study id numbers
  • CL2-90652-002

Eligibility Criteria

Eligible age for the study

30 months to 17 years (Child)

Sex

Male/Female

Accepts Healthy Volunteers

No

  • * Hypertensive children, who have been treated for four months at least with S90652, with safety and efficacy

  • * Poorly controlled hypertension
  • * Girls with signs of pubescence

How is the study designed?

Allocation
Non-randomized
Interventional study model
Single Group

Keywords

Additional Relevant MeSH Terms Glioma
Hypertension